Portal de Periódicos da CAPES

Modulatory Actions of Corticotropin‐releasing Factor–binding Protein a

1996; Wiley; Volume: 780; Issue: 1 Linguagem: Inglês

10.1111/j.1749-6632.1996.tb15113.x

1749-6632

Dominic P. Behan, Errol B. De Souza, E Potter, Paul E. Sawchenko, Philip J. Lowry, Wylie Vale,

Hormonal Regulation and Hypertension

Annals of the New York Academy of SciencesVolume 780, Issue 1 p. 81-95 Modulatory Actions of Corticotropin-releasing Factor–binding Protein† DOMINIC P. BEHAN, DOMINIC P. BEHAN bNeurocrine Biosciences Inc. 3050 Science Park Road San Diego, California 92121Search for more papers by this authorERROL B. DE SOUZA, ERROL B. DE SOUZA bNeurocrine Biosciences Inc. 3050 Science Park Road San Diego, California 92121Search for more papers by this authorELLEN POTTER, ELLEN POTTER cClayton Foundation Laboratories for Peptide Biology The Salk Institute, La Jolla San Diego, California 92037Search for more papers by this authorPAUL SAWCHENKO, PAUL SAWCHENKO cClayton Foundation Laboratories for Peptide Biology The Salk Institute, La Jolla San Diego, California 92037Search for more papers by this authorPHILIP J. LOWRY, PHILIP J. LOWRY dDepartment of Biochemistry and Physiology Reading University Reading RG6 2AJ, EnglandSearch for more papers by this authorWYLIE W. VALE, WYLIE W. VALE cClayton Foundation Laboratories for Peptide Biology The Salk Institute, La Jolla San Diego, California 92037Search for more papers by this author DOMINIC P. BEHAN, DOMINIC P. BEHAN bNeurocrine Biosciences Inc. 3050 Science Park Road San Diego, California 92121Search for more papers by this authorERROL B. DE SOUZA, ERROL B. DE SOUZA bNeurocrine Biosciences Inc. 3050 Science Park Road San Diego, California 92121Search for more papers by this authorELLEN POTTER, ELLEN POTTER cClayton Foundation Laboratories for Peptide Biology The Salk Institute, La Jolla San Diego, California 92037Search for more papers by this authorPAUL SAWCHENKO, PAUL SAWCHENKO cClayton Foundation Laboratories for Peptide Biology The Salk Institute, La Jolla San Diego, California 92037Search for more papers by this authorPHILIP J. LOWRY, PHILIP J. LOWRY dDepartment of Biochemistry and Physiology Reading University Reading RG6 2AJ, EnglandSearch for more papers by this authorWYLIE W. VALE, WYLIE W. VALE cClayton Foundation Laboratories for Peptide Biology The Salk Institute, La Jolla San Diego, California 92037Search for more papers by this author First published: June 1996 https://doi.org/10.1111/j.1749-6632.1996.tb15113.xCitations: 19 † This work was supported in part by NIH Grant DK 26741, NIH Grant DK 07044, the Adler Foundation, and by the Foundation for Research, Inc. (W. W. Vale is a Foundation for Research Principal Investigator). We would like to thank the British Medical Research Council, the Welcome Trust (England, P. J. Lowry), and the Reading University Endowment Fund (England, P. J. Lowry) for funding this work. The work at Neurocrine Biosciences was supported by a National Institute of Neurological Disorders and Stroke Small Business Innovative Research (SBIR) Grant (NS33426). AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat References 1 Linton, E. A. & P. J. Lowry. 1986. A large molecular weight carrier for CRF-41 in human plasma. J. Endocrinol. Suppl. 111: 150. 2 Orth, D. N. & C. D. Mount. 1987. Specific high affinity binding protein for human corticotropin-releasing hormone in normal human plasma. Biochem. Biophys. Res. Commun. 143: 411–417. 3 Linton, E. A., C. D. A. Wolfe, D. P. Behan & P. J. Lowry. 1988. A specific carrier substance for human corticotropin-releasing factor in late gestational maternal plasma which could mask the ACTH-releasing activity. Clin. Endocrinol. 28: 315–324. 4 Suda, T., M. Iwashita, F. Tozawa, T. Ushiyama, N. Tomori, T. Sumitomo, Y. Naka-Gami, H. Demura & K. Shizume. 1988. Characterization of CRH binding protein in human plasma by chemical cross-linking and its binding during pregnancy. J. Clin. Endocrinol. Metab. 67: 1278–1283. 5 Ellis, M. J., J. H. Livesey & R. A. Donald. 1988. Circulating plasma corticotropin-releasing factor-like immunoreactivity. J. Neuroendocrinol. 117: 299–307. 6 Behan, D. P., E. A. Linton & P. J. Lowry. 1989. Isolation of the human plasma corticotrophin-releasing factor-binding protein. J. Endocrinol. 122: 23–31. 7 Linton, E. A., D. P. Behan, P. W. Saphier & P. J. Lowry. 1989. Corticotropin-releasing hormone binding protein: Reduction in the ACTH-releasing activity of placental but not hypothalamic CRH. J. Clin. Endocrinol. Metab. 70: 1574–1580. 8 Potter, E., D. P. Behan, W. H. Fischer, E. A. Linton, P. J. Lowry & W. W. Vale. 1991. Cloning and characterization of the cDNAs for human and rat corticotropin-releasing factor-binding proteins. Nature 349: 432–426. 9 Suda, T., T. Sumitomo, F. Tozawa, T. Ushiyama & H. Demura. 1989. Corticotropin-releasing factor-binding protein is a glycoprotein. Biochem. Biophys. Res. Commun. 165: 703–707. 10 Fischer, H. W., D. P. Behan, M. Park, E. Potter, P. J. Lowry, & W. Vale. 1994. Assignment of disulfide bonds in corticotropin releasing factor-binding protein. J. Biol. Chem. 6: 4313–4316. 11 Gilbert, W. 1978. Why genes in pieces. Nature 271: 501–5012. 12 Behan, D. P., E. Potter, K. A. Lewis, N. A. Jenkins, N. Copeland, P. J. Lowry & W. Vale. 1993. Cloning and structure of the human corticotrophin releasing factor-binding protein gene (CRHBP). Genomics 16: 63–68. 13 Hardon, E. M., M. Frain, G. Paonessa & R. Corteses. 1988. Two distinct factors interact with the promoter regions of several liver-specific genes. EMBO J. 7: 1711–1719. 14 Lenardo, J. M. & D. Baltimore. 1989. NF-kB: A pleotrophic mediator of inducible and tissue-specific gene control. Cell 58: 227–229. 15 Fujita, T., H. Shibuya, H. Hotta, K. Yamanishi & T. Taniguchi. 1987. Interferon-β gene regulation: Tandemly repeated sequences of a synthetic 6 bp oligomer function as a virus-inducible enhancer. Cell 49: 357–367. 16 Barclay, N. A., P. Johnson, G. W. McCaughan & A. F. Williams. 1988. The T-cell Receptors 53–58. Plenary Press. New York . 17 Vaccaro, M., A. Pawlak & J. P. Jost. 1990. Positive and negative regulatory elements of chicken vitellogenin II gene characterized by in vitro transcription competition assays in a homologous system. Proc. Natl. Acad. Sci. USA 87: 3047–3051. 18 Sutton, S. W., D. P. Behan, L. L. Sabine, R. Kaiser, A. Corrigan, P. Lowry, E. Potter, M. H. Perrin, J. Rivier, W. Vale. 1995. Ligand requirements of the human corticotropin releasing factor-binding protein. Endocrinology 136: 1097–1102. 19 Suda, T., N. Tomori, F. Yajima, T. Sumitomo, Y. Nakagami, T. Ushiyama, H. Demura & K. Shizume. 1985. Immunoreactive corticotropin-releasing factor in human plasma. J. Clin. Invest. 76: 2026–2029. 20 Nieuwenhuyzen Kruseman, A. C., E. A. Linton, J. F. Ackland, G. M. Besser & P. J. Lowry. 1984. Heterogeneous immunocytochemical reactivities of o-CRF-like material in the human hypothalamus, pituitary and G.I. tract. Neuroendocrinology 38: 212–216. 21 Petrusz, P., I. Merchanthaller, J. L. Maderdrut, S. Vigh & A. Schally. 1983. Corticotrophin-releasing factor-like immunoreactivity in the vertebrate endocrine pancreas. Proc. Natl. Acad. Sci. USA 80: 1721. 22 Crofford, L. J., H. Sano, K. Karalis, T. C. Friedman, H. R. Epps, E. F. Remmers, P. Mathern, G. P. Chrousos, R. L. Wilder. 1993. Corticotropin-releasing hormone in synovial fluids and tissues of patients with rheumathoid arthritis and osteoarthritis. J. Immunol. 151: 1587–1596. 23 Sasaki, A., A. S. Liotta, M. M. Luckey, A. N. Margioris, T. Suda & D. Krieger. 1984. Immunoreactive corticotropin-releasing factor is present in human maternal plasma during the third trimester of pregnancy. J. Clin. Endocrinol. Metab. 59: 812–814. 24 Campbell, E. A., E. A. Linton, C. D. A. Wolfe, P. R. Scraggs, M. T. Jones & P. J. Lowry. 1987. Plasma corticotropin-releasing hormone concentrations during pregnancy and parturition. J. Clin. Endocrinol. Metab. 64: 1054–1059. 25 Linton, E. A., C. McLean, K. Nieuwenhuysen, F. J. van Tilders, E. A. der Veen, P. J. Lowry. 1987. Direct measurement of human plasma corticotropin-releasing hormone by two-siteč immunoradiometric assay. J. Clin. Endocrinol. Metab. 64: 1047–1053. 26 Goland, R. S., S. L. Starle, L. S. Brown & A. G. Frantz. 1986. High levels of CRF immunoreactivity in maternal and fetal plasma during pregnancy. J. Clin. Endocrinol. Metab. 63: 199–203. 27 Linton, E. A., A. V. Perkins, R. J. Woods, F. Eben, C. D. A. Wolfe, D. P. Behan, E. Potter, W. W. Vale & P. J. Lowry. 1993. Corticotropin-releasing hormone-binding protein (CRH-BP): Plasma levels decrease during the third trimester of normal human pregnancy. J. Clin. Endocrinol. Metab. 76: 260–262. 28 Woods, R. J., P. Grossman, P. Saphier, K. Kennedy, E. Ur, D. Behan, E. Potter, W. Vale & P. J. Lowry. 1994. Association of human corticotropin-releasing hormone to its binding protein in blood may trigger clearance of the complex. J. Clin. Endocrinol. Metab. 78: 73–76. 29 Suda, T., M. Iwasita, T. Sumitomo, Y. Nakanao, F. Tozawa, T. Ushiyama & H. Demura. 1990. Glucocorticoids decrease binding of CRF-BP in human plasma. J. Clin. Endocrinol. Metab. 71: 913–917. 30 Saphier, P. W., M. Faria, A. Grossman, D. H. Coy, G. M. Besser, B. Hodson, M. Parkes, E. A. Linton & P. J. Lowry. 1992. A comparison of the clearance of ovine and human corticotrophin-releasing hormone (CRH) in man and sheep: A possible role for the CRH-binding protein. J. Endocrinol. 133: 487–495. 31 Woods, R. W., K. M. Kennedy, J. M. Gibbins, D. P. Behan, W. Vale & P. J. Lowry. 1994. Corticotropin releasing factor binding protein dimerizes after association with ligand. Endocrinology 135: 768–773. 32 Perkins, A. V., F. Eben, C. D. A. Wolfe, H. M. Schulte & E. A. Linton. 1993. Plasma measurements of corticotropin-releasing hormone-binding protein in normal and abnormal human pregnancy. J. Endocrinol. 138: 149–157. 33 McLean, M., A. Bisits, J. Davies, R. Woods, P. Lowry, & R. Smith. 1995. A placental clock controlling the length of human pregnancy. Nature Medicine 1: 460–463. 34 Webster, E. L. & E. B. De Souza. 1988. Corticotropin-releasing factor receptors in mouse spleen: Identification, autoradiographic localization, and regulation by divalent cations and guanine nucleotides. Endocrinology 122: 609–617. 35 McGllis, J. P., A. Park, P. Rubin-Fletter, C. Turck, M. F. Dallman, & D. G. Payan. 1989. Stimulation of rat B-lymphocyte proliferation by corticotropin-releasing factor. J. Neurosci. Res. 23: 346–352. 36 Dave, R. J., L. E. Eiden & R. L. Eskay. 1985. Corticotropin-releasing factor binding to peripheral tissue and activation of the adenylate cyclase-adenosine 3č,5č-monophosphate system. Endocrinology 116: 2152–2159. 37 Aguilera, G., M. A. Millan, R. L. Hauger & K. J. Catt. 1987. Corticotropin-releasing factor receptors: Distribution and regulation in brain, pituitary, and peripheral tissues. Ann. N. Y. Acad. Sci. 512: 48–66. 38 Kiang, J. G. & E. T. Wei. 1987. Corticotropin-releasing factor inhibits thermal injury. J. Pharmacol. Exp. Ther. 243: 517–520. 39 Irwin, M. R., W. Vale & K. T. Britton. 1987. Central corticotropin-releasing factor suppresses natural killer cell toxicity. Brain Behav. Immun. 1: 81–87. 40 Potter, E., D. P. Behan, E. A. Linton, P. J. Lowry, P. E. Sawchenko & W. W. Vale. 1992. The central distribution of a corticotropin-releasing factor (CRF)-binding protein predicts multiple sites and modes of interaction with CRF. Proc. Natl. Acad. Sci. USA 89: 4192–4196. 41 De Souza, E. B., T. R. Insel, M. H. Perrin, J. Rivier, W. W. Vale & M. J. Kuhar. 1985. Differential regulation of corticotropin-releasing factor receptors in anterior and intermediate lobes of pituitary and in brain following adrenalectomy in rats. Neurosci. Lett. 56: 121–128. 42 De Souza, E. B., P. J. Whitehouse, M. J. Kuhar, D. L. Price & W. W. Vale. 1986. Reciprocal changes in corticotropin-releasing factor (CRF)-like immunoreactivity and CRF receptors in cerebral cortex of Alzheimerčs disease. Nature 319: 593–595. 43 Behan, D. P., S. C. Heinrichs, J. C. Troncoso, X. Liu, C. H. Kawas, N. Ling & E. B. DeSouza. 1995. Displacement of corticotropin releasing factor from its binding protein as a possible treatment for Alzheimerčs disease. Nature 378: 284–287. 44 Grand, R. J. A. 1989. Acylation of viral and eukaryotic proteins. Biochem. J. 258: 625–638. 45 Hancock, J. F., A. I. Magee, J. E. Chids & C. J. Marshall. 1989. All ras proteins are polyisoprenylated but only some are palmitoylated. Cell 57: 1167–1177. 46 Seabra, M. C., M. S. Brown, C. A. Slaughter, T. C. Sudhof & J. L. Goldstein. 1992. Purification of component A of Rab geranylgeranyl transferase: Possible identity with choroideremia gene product. Cell 70: 1049–1057. 47 Low, M. 1989. Glycosyl-phosphatidylinositol: A versitile anchor for cell surface proteins. FASEB J. 3: 1600–1608. 48 Fricker, L. D., B. Das & R. Hogue Angelletti. 1990. Identification of a pH-dependent membrane anchor of carboxypeptidase E [EC 3.4.17.10]. J. Biol. Chem. 265: 2476–2482. 49 Chrousos, G. P. & P. W. Gold. 1992. The concepts of stress and stress system disorders. J. Am. Med. Assoc. 267: 1244–1252. 50 Olson, J. A., K. T. Shiverick, S. Olivie, W. C. Buhi & M. K. Raizada. 1991. Developmental expression of rat insulin-like growth factor binding protein-2 by astrocytic glial cells. Endocrinology 129: 1066–1074. 51 Paolo, G., P. J. Fielder, W. J. Henzel, A. Louie, S. M. Donovan, A. R. Hoffman & R. G. Rosenfeld. 1991. Differential effects of insulin-like growth factor (IGF)-(IGFBPs) in a rat neuroblastoma cell line: Isolation and characterization of two forms of IGFBP-4. Endocrinology 128: 2815–2824. 52 Monireh, R., C. Lassarre, J. Zapf, G. Pova & M. Binoux. 1991. Two insulin-like growth factor (IGF)-binding proteins are responsible for the selective affinity for IGF-II of cerebrospinal fluid binding proteins. J. Clin. Endocrinol. 73: 658–666. 53 Hoffman, B. J., E. Mezey & M. J. Brownstein. 1991. Cloning of a seretonin transporter affected by antidepressants. Science 254: 579–580. 54 Pacholozyk, T., R. D. Blakely & S. G. Amara. 1991. Expression cloning of a cocaine-antidepressant sensitive human noradrenaline transporter. Nature 350: 350–353. 55 Guastella, J., N. Nelson, H. Nelson, L. Czyzyk, S. Keynan, M. C. Miedel, N. Davidson, H. A. Lester & B. I. Kunner. 1990. Cloning and expression of a rat brain GABA transporter. Science 249: 1303–1306. Citing Literature Volume780, Issue1Neuropeptides: Basic and Clinical AdvancesJune 1996Pages 81-95 ReferencesRelatedInformation